📉 Which biotechs have PDUFA dates between September 2025 and January 2026 and are currently in Phase III trials?

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking for biotech stocks with PDUFA dates between September 2025 and January 2026 that are currently in Phase III trials. First, I need to check the provided references for any relevant data. Looking through the references, I see several entries related to PDUFA dates and Phase III trials. Let's go through them one by one. Reference 1 mentions a query for biotech stocks with PDUFA dates between Sep 1, 2025, and Jan 1, 2026, and Phase III trials, but the result is 0. That's a red flag because the user is asking for exactly that. However, other references might have relevant info. References 2-10 are about specific companies like Microsoft, OS Therapies, Aptose Biosciences, HCW Biologics, NRx Pharmaceuticals, etc. Let's check each for PDUFA dates and Phase III status. OS Therapies (References 3,7,8,9,12) has a PDUFA date mentioned in the query (Reference 12) but the result is 0. However, their Phase 2b trial data is discussed, not Phase III. So they might not fit. Aptose Biosciences (References 4,13,14,15,16,18) has a query for a PDUFA date in October 2025 (Reference 18), but the result is 0. Their trials are Phase 1/2, not Phase III. HCW Biologics (References 5,19,20,21,22,24) has a query for a PDUFA date in November 2025 (Reference 24), but the result is 1. However, the stock code and name are provided, but the PDUFA date is November 2025, which is within the user's timeframe. The trial mentioned is Phase 1 for HCW9302, not Phase III. NRx Pharmaceuticals (References 6,25,26,27,28,30) has a query for a PDUFA date in December 2025 (Reference 30), result 0. Their trials are Phase 2b/3, which is close to Phase III but not exactly Phase III. Looking at the FDA Calendar references (31,32,33,34,36,42), there are PDUFA dates listed, but none fall exactly between Sep 2025 and Jan 2026. The closest is September 2025, but the results are 0. The user's previous questions and the assistant's responses mention companies like Agios and Abeona, but their PDUFA dates are already passed or not in the specified timeframe. Given all this, the references don't provide any biotech stocks with PDUFA dates between Sep 2025 and Jan 2026 that are in Phase III trials. The queries in the references either have 0 results or the trials are not Phase III. Therefore, the answer should reflect that no such stocks are found based on the provided data. ``` ### 🌟 **Conclusion** **No biotech stocks** with **PDUFA dates between September 2025 and January 2026** and **Phase III trials** were found in the provided data. --- ### 📊 **Analysis** #### 🌟 **Key Findings** 1. **PDUFA Date Queries**: - **Query 1**: Biotech stocks with PDUFA dates between Sep 1, 2025, and Jan 1, 2026, and Phase III trials → **0 results** . - **Query 12**: OS Therapies (OSTX) PDUFA date September 2025, Phase III trial → **0 results** . - **Query 18**: Aptose Biosciences (APTOF) PDUFA date October 2025, Phase III trial → **0 results** . - **Query 24**: HCW Biologics (HCWB) PDUFA date November 2025, Phase III trial → **1 result** (but trial is Phase 1) . - **Query 30**: NRx Pharmaceuticals (NRXP) PDUFA date December 2025, Phase III trial → **0 results** . 2. **FDA Calendar Data**: - No PDUFA dates for biotech stocks in the specified timeframe (Sep 2025–Jan 2026) were listed in the FDA calendar references . 3. **Phase III Trials**: - Companies like **OS Therapies** (OSTX) and **Aptose Biosciences** (APTOF) are mentioned in the data, but their trials are in **Phase 2b** and **Phase 1/2**, respectively . - **NRx Pharmaceuticals** (NRXP) is conducting **Phase 2b/3** trials for NRX-101, but no confirmed PDUFA date in the specified timeframe . --- ### 📊 **Key Takeaways** - **No confirmed PDUFA dates** for biotech stocks in the Sep 2025–Jan 2026 timeframe with Phase III trials. - **OS Therapies** (OSTX) and **Aptose Biosciences** (APTOF) are advancing promising therapies, but their trials are not yet Phase III. - **NRx Pharmaceuticals** (NRXP) has Phase 2b/3 data but no confirmed PDUFA date in the specified timeframe. --- ### 🌟 **Final Call** For investors tracking **FDA-driven catalysts**, there are **no biotech stocks** meeting the criteria of **PDUFA dates between Sep 2025–Jan 2026** and **Phase III trials** based on the provided data. Stay tuned for updates as companies like **OSTX** and **APTOF** progress their pipelines.